Arama Sonuçları
Tüm Sonuçları Gör
Home
Gruplar
Sayfalar
Marketplace
Daha fazla gör
Gruplar
Sayfalar
Marketplace
Blogs
Katıl
Giriş yapın
Başvur
Theme Switcher
Day Mode
LiveScience
@LiveScience
paylaşılan bir bağlantı
2025-02-11 02:44:41
·
Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs
www.livescience.com
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
0 Yorumlar
·
0 hisse senetleri
·
66 Views
Please log in to like, share and comment!
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade